Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
Severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 are enveloped, positive-sense, single-stranded RNA viruses and causes of epidemic diseases that have resulted in public health emergencies worldwide. Angiotensin-converting enzyme 2 (ACE2) is the receptor that allows the entry o...
Main Authors: | Lin Wang, Ye Xiang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/12/11/1289 |
Similar Items
-
An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome–Coronavirus
by: Muthu Kumaradoss Kathiravan, et al.
Published: (2021-03-01) -
The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies
by: Anastassios C. Papageorgiou, et al.
Published: (2020-10-01) -
Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
by: Gary R. Whittaker, et al.
Published: (2012-06-01) -
Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein
by: Yue Xing, et al.
Published: (2020-07-01) -
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
by: Liangwei Duan, et al.
Published: (2020-10-01)